Adjuvant Therapy‐Related Shortening of Survival (ATRESS): An Underrated Phenomenon

Shortening of survival after dissemination following adjuvant treatment is not understood well enough and is difficult to search for in public databases because of the lack of specific search terms. We suggest using the acronym ATRESS, for “adjuvant therapy‐related shortening of survival,” in future...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2015-01, Vol.20 (1), p.88-88
Hauptverfasser:	Fink, Michael K., Kleeberg, Ulrich R., Bartels, Stefan
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast Neoplasms - drug therapy Breast Neoplasms - mortality Deoxycytidine - analogs & derivatives Female Fluorouracil - analogs & derivatives Humans Letters to the Editor Taxoids - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Shortening of survival after dissemination following adjuvant treatment is not understood well enough and is difficult to search for in public databases because of the lack of specific search terms. We suggest using the acronym ATRESS, for “adjuvant therapy‐related shortening of survival,” in future literature concerning this issue.
ISSN:	1083-7159 1549-490X
DOI:	10.1634/theoncologist.2014-0273